-
Mashup Score: 0Bivalirudin Found to be Safer and More Effective Than Heparin for Treating Heart Attack Patients Undergoing Percutaneous Coronary Intervention - 1 year(s) ago
November 14, 2022 — Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can lower the risk of death or major bleeding by 31 percent. These are findings from a new study led by researchers from the Icahn School of Medicine at Mount Sinai. This is the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
This week we review a recent work on the use of bivalirudin on outcomes of pediatric VAD patients. W
Source: SpreakerCategories: Cardiologists, Latest HeadlinesTweet-
📣 New Podcast! "Pediheart Podcast #179: Bivalirudin Use For Pediatric Ventricular Assist Devices" on @Spreaker #anticoagulation #bivalirudin #cardioed #cardiologia #cardiologie #cardiology #cardiotwitter #criticalcare #heartfailure #heparin #science https://t.co/V5B91zNqcV
-
-
Mashup Score: 0
Bivalirudin yielded similar 30-day mortality rates to heparin following percutaneous coronary intervention in heart attack patients.
Source: Docwire NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet-
BIVALIRUDIN EDGES HEPARIN: In a New Analysis of Pooled Trial Data Presented at #TCT2020, #Bivalirudin Was Linked with Lower Mortality and Lower Bleeding Risk in Some Heart Attack Patients Versus #Heparin https://t.co/9cGrBVVelu
-
@DAICeditor @MountSinaiNYC #Bivalirudin is a safer and more effective #anticoagulant than #heparin for treating patients with the most serious type of #heartattacks who undergo urgent #PCI, and can lower the risk of death or major bleeding by 31%: https://t.co/aPpKKg5tUJ